Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2386 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Regulus Therapeutics raises $20m in equity financing

Regulus Therapeutics, a biopharmaceutical company, Alnylam Pharmaceuticals, and Isis Pharmaceuticals have announced that Regulus has raised $20m in a series A preferred equity financing. Alnylam and Isis were

Applied Biosystems and TGen form research alliance

As part of this alliance, a team of scientists from Translational Genomics Research Institute (TGen) and Applied Biosystems will employ the SOLiD 3 system, Applied Biosystems’s next-generation genomic

Uluru’s CEO resigns

The company has also appointed Renaat Hooff to assume the position of president and CEO. Mr Hooff was previously the company’s executive vice president of operations. William Crouse,

Del Medical Systems to relocate headquarters

Del’s new headquarters, a 22,000 square foot facility in the Turnberry Lakes Technology Park will feature a digital showroom that will be used as a walk-through showcase of